Alex Gifford

Associate Professor

University Hospital

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Alex Gifford is an Associate Professor at University Hospitals in the United States. His research focuses on cystic fibrosis, particularly the clinical outcomes of modulator therapy and the management of gastrointestinal medication regimens. He has published recent articles on topics such as telehealth barriers during the COVID-19 pandemic and the effects of proton pump inhibitors on hemoglobin levels in cystic fibrosis patients.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

University of Florida

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alex Gifford

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Update on Clinical Outcomes of Highly Effective Modulator Therapy.

Need to study simplification of gastrointestinal medication regimen in cystic fibrosis in the era of highly effective modulators.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.

Evaluating barriers to and promoters of telehealth during the COVID-19 pandemic at U.S. cystic fibrosis programs

Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis

A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends.

Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Study Design.

Formative evaluation of a dashboard to support coproduction of healthcare services in cystic fibrosis

Availability of Zinc Impacts Interactions between Streptococcus sanguinis and Pseudomonas aeruginosa in Coculture.

Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy

Collaborators (5)

George Retsch-Bogart

Theresa Laguna

MinJae Lee

Rachel Linnemann

Silvia Maria del Rocio Delgado Villalta

Make your next move.